Back to Studies Overview

The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information:

Study Name on
Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients (PsAer-IgY)
Study Drug Avian Polyclonal Anti-Pseudomonas Antibodies (IgY)
Type of Study Drug Anti-infective
Study Title Phase III Study to Evaluate Clinical Efficacy and Safety of Avian Polyclonal Anti-Pseudomonas Antibodies (IgY) in Prevention of Recurrence of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients
Study Phase 3
Study Sponsor Mukoviszidose Institut gGmbH
Link on

Additional information: 
(in German language)

Participating ECFS-CTN sites

Belgium: Leuven
Germany: Berlin, Frankfurt, Hannover, Köln
Italy: Firenze, Genoa, Rome, Verona
Spain: Barcelona
Sweden: Stockholm


5 years and older

Back to Studies Overview